The role of exercise training frequency in long-term blood pressure control

ISRCTN ISRCTN62287921
DOI https://doi.org/10.1186/ISRCTN62287921
Secondary identifying numbers 19/SAS/12C
Submission date
12/06/2025
Registration date
16/06/2025
Last edited
18/06/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
High blood pressure is a major risk factor for heart disease. Recent research suggests that performing isometric wall squat exercise training can significantly reduce blood pressure. This study aimed to find out how the frequency of wall squat training affects blood pressure and cardiovascular health, and whether stopping the exercise leads to a reversal of benefits.

Who could take part?
Adults aged 18–65 years with normal to slightly raised blood pressure (systolic 120–139 mmHg) who were not taking blood pressure medication and had no known cardiovascular, metabolic, or musculoskeletal conditions.

What did the study involve?
Participants were randomly allocated to one of five groups. All groups completed wall squat training three times per week for the first 4 weeks. In the second 4-week phase, training frequency varied: participants either continued training at three, two or one time per week, stopped training entirely, or were in a control group with no training throughout. Blood pressure and other cardiovascular measurements were taken at baseline, mid-point (week 4), and after 8 weeks.

What were the possible benefits and risks of taking part?
Participants may have experienced improvements in blood pressure. The exercise is low-risk but may have caused some temporary muscle discomfort. All procedures were designed to be safe and accessible to people with no prior exercise experience.

Where was the study run from?
The study was conducted at Canterbury Christ Church University (CCCU), within the School of Psychology and Life Sciences.

When did the study take place and how long did it run for?
September 2019 to March 2025

Who funded the study?
The study was funded internally by Canterbury Christ Church University as part of a postgraduate research degree

Who was the main contact?
Dr Harry Swift, harry.swift@canterbury.ac.uk

Contact information

Dr Harry Swift
Principal Investigator

North Holmes Road
Canterbury
CT1 1QU
United Kingdom

ORCiD logoORCID ID 0000-0003-0499-5706
Phone +44 (0)1227470442
Email harry.swift@canterbury.ac.uk
Dr Damian Coleman
Scientific

North Holmes Road
Canterbury
CT1 1QU
United Kingdom

ORCiD logoORCID ID 0000-0002-7332-8221
Phone +44 (0)1227 767700
Email damian.coleman@canterbury.ac.uk
Dr Jim Wiles
Public

North Holmes Road
Canterbury
CT1 1QU
United Kingdom

ORCiD logoORCID ID 0000-0002-7790-8063
Phone +44 (0)1227 767700
Email jim.wiles@canterbury.ac.uk

Study information

Study designSingle-centre interventional randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)University/medical school/dental school
Study typeEfficacy
Participant information sheet 47478_PIS.pdf
Scientific titleUnderstanding dose-response in isometric exercise training: the role of training frequency in long-term blood pressure control
Study objectivesIncreasing the frequency of isometric exercise training will result in greater improvements in blood pressure, vascular resistance, and autonomic function in normotensive to pre-hypertensive adults, compared to lower-frequency training or no training.
Ethics approval(s)

Approved 19/12/2019, Canterbury Christ Church University ethics board (School of Psychology and Life Sciences, Canterbury Christ Church University, Kent, Canterbury, CT1 1QU, United Kingdom; +44 (0)1227767700; red.resgov@canterbury.ac.uk), ref: 19/SAS/12C

Health condition(s) or problem(s) studiedPrevention of hypertension in normotensive to pre-hypertensive adults through isometric exercise training
InterventionAll participants are randomly assigned using stratified random allocation to one of five groups. During the first 4 weeks, all intervention groups complete isometric wall squat training three times per week, consisting of four 2-minute bouts at 95% peak heart rate, with 2 minutes rest between bouts. In the final 4 weeks, training frequency is modified: participants either continue training at 3x/week, reduce to 2x/week, reduce to 1x/week, stop training entirely, or remain in the control group with no training throughout.

Training is supervised or remotely monitored to ensure adherence. Assessments are conducted at baseline, mid-point (week 4), and end-point (week 8), measuring resting blood pressure, cardiac output, total peripheral resistance, heart rate variability, and baroreflex sensitivity.
Intervention typeOther
Primary outcome measureResting systolic blood pressure (SBP) is measured using the Task Force® Monitor during a 5-minute seated continuous recording at baseline, week 4, and week 8
Secondary outcome measures1. Mean arterial pressure (MAP) is calculated from continuous blood pressure data recorded by the Task Force® Monitor during a 5-minute seated period at baseline, week 4, and week 8
2. Diastolic blood pressure (DBP) is measured using the Task Force® Monitor during the same 5-minute seated recording at baseline, week 4, and week 8
3. Total peripheral resistance (TPR) is derived from concurrent blood pressure and cardiac output signals via the Task Force® Monitor during a 5-minute seated measurement at baseline, week 4, and week 8
4. Cardiac output (Q̇) and stroke volume (SV) are recorded via impedance cardiography using the Task Force® Monitor during a 5-minute seated recording at baseline, week 4, and week 8
5. Heart rate variability (HRV) metrics (LF, HF, LFnu, HFnu, LF/HF ratio) are calculated from ECG data obtained via the Task Force® Monitor during the 5-minute seated period at baseline, week 4, and week 8
6. Baroreflex sensitivity (BRS) is assessed using sequence and spectral methods applied to the 5-minute continuous Task Force® Monitor data at baseline, week 4, and week 8
Overall study start date01/09/2019
Completion date01/03/2025

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
Upper age limit65 Years
SexBoth
Target number of participants118
Total final enrolment100
Key inclusion criteria1. Male and female participants with normal to high-normal sBP (range 120-140 mmHg)
2. University staff and students from Canterbury Christ Church University and their associates via social media and word of mouth
3. Total weekly physical activity level below the 150 minutes of moderate physical activity per week, or specifically ≤600 MET-minutes, calculated as the sum of all light-intensity activities (light walking = 3.3 METs, light cycling = 3.0 METs, household work = 2.5 METs). Total MET-minutes were computed as MET × duration (min). To exclude structured exercise, any reported bout ≥4 METs lasting ≥ 10 minutes (e.g. jogging and weight training) led to exclusion.
4. Free from any injuries or illnesses
5. Not taking any medication (or had previously taken any anti-hypertensive medication)
6. Non-smokers
7. Consumed less than 14 units of alcohol per week
8. Screening was conducted using a standard Physical Activity Readiness Questionnaire
9. Provided written informed consent
Key exclusion criteria1. Free from any injuries or illnesses
2. Not taking any medication (or had previously taken any anti-hypertensive medication)
3. Non-smokers
4. Consumed less than 14 units of alcohol per week
Date of first enrolment21/01/2020
Date of final enrolment16/08/2024

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Canterbury Christ Church University
St. Georges Place
Canterbury
CT1 1UT
United Kingdom

Sponsor information

Canterbury Christ Church University
University/education

North Holmes Road
Canterbury
CT1 1QU
England
United Kingdom

Phone +44 (0)1227 767700
Email graduatecollege@canterbury.ac.uk
Website https://www.canterbury.ac.uk/
ROR logo "ROR" https://ror.org/0489ggv38

Funders

Funder type

University/education

Canterbury Christ Church University
Private sector organisation / Universities (academic only)
Location
United Kingdom

Results and Publications

Intention to publish date03/03/2025
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryStored in publicly available repository
Publication and dissemination planResults from this study will be published in a peer-reviewed journal and a PhD thesis.
IPD sharing planThe datasets generated during and/or analysed during the current study will be stored in a publicly available repository.
The dataset is stored in the UK Data Service ReShare repository.
The dataset includes fully anonymised individual-level data on blood pressure, heart rate variability, cardiac output, and vascular resistance across three timepoints (baseline, week 4, week 8), as well as group allocation and basic demographics (age, sex).
Data will be made available indefinitely through the UK Data Service under standard academic licensing terms.
Access will be open to registered users for non-commercial research and teaching purposes, subject to acceptance of a user agreement.
No personally identifiable data are included. Anonymisation involved the removal of names, dates, and indirect identifiers, and aggregation of sensitive subgroups where needed.
Informed consent for data sharing was obtained from participants via approved ethics documentation, and the study was reviewed and approved by Canterbury Christ Church University’s ethics committee.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet 13/06/2025 No Yes
Basic results 18/06/2025 18/06/2025 No No

Additional files

47478_PIS.pdf
47478_BasicResults_18Jun25.pdf

Editorial Notes

18/06/2025: Basic results uploaded.
12/06/2025: Study's existence confirmed by Canterbury Christ Church University.